MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Non-motor symptoms in ACDY5-associated disease

C. Amlang, M. Vidailhet, M. Amlang (Bronx, NY, USA)

Meeting: 2017 International Congress

Abstract Number: 634

Keywords: Behavioral abnormalities, Cognitive dysfunction

Session Information

Date: Tuesday, June 6, 2017

Session Title: Rare Genetic and Metabolic Diseases

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To describe non-motor symptoms in a case of ACDY5-associated disease.

Background: The hereditary dyskinesia syndrome caused by an ACDY5 mutation was first described in 2001. To date, 46 patients with 6 different mutations have been described in the literature. Patients present during childhood or adolescence with choreiform movements, facial myokymia, dystonia, gait abnormality, abnormal saccadic eye movement and developmental delay.

Methods: We conducted a review of the literature by using the search terms “ACDY5,” “movement disorders,” “tics,” “cognition,” and “behavior” on PubMed. We report the case of a patient with an ACDY5 mutation who exhibited, in addition to the classical movement disorders phenotype, a broader spectrum of symptoms including tics, oppositional behavior and neuropsychological deficits with depression and cognitive impairment.

 

Results: The 11-year old boy with ACDY5 mutation presented since age 3 with mixed hyperkinetic disorder marked by choreatic movements of the extremities and the trunk as well as facial myokymia. His paroxysmal, mostly spontaneous attacks lasted 30s to 9min with dystonic and clonic movements of the extremities and oral movements without loss of consciousness or EEG findings.

At age 10, his condition was complicated by motor and vocal tics. He started repeating words multiple times, stamping his feet, hitting the table with his hands, and using insulting words. His symptoms worsened with stress or lack of sleep.

He also developed depression and disturbed social behavior. His social behavior disorders were marked by, among other, stealing, lying, aggression against siblings and classmates or breaking car glasses.

He showed a delayed motor and speech development complicated by cognitive impairments requiring intensive support at school. Two different intelligence tests were performed, a SON-R at age 6 with average results within normal limits and a WISC at age 10 with a result of 65.

 

 

Conclusions: ADCY5 mutations are the cause for a rare hereditary dyskinetic syndrome with a broad spectrum of movement disorders. Cognitive impairments may complicate the condition; however, it is unclear to which extent ADCY5 plays a role in cognitive development. Intellectual disabilities were reported in 10% and delayed language development in 30% of patients. We further expand the spectrum of motor and non-motor symptoms in ADCY5-associated diseases, as tics and behavior disorders have not yet been reported in the literature.

To cite this abstract in AMA style:

C. Amlang, M. Vidailhet, M. Amlang. Non-motor symptoms in ACDY5-associated disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/non-motor-symptoms-in-acdy5-associated-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/non-motor-symptoms-in-acdy5-associated-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley